Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Council approves AstraZeneca funding revisions, schematic development plan amendment for 200 Orchard Ridge Drive
Summary
The Gaithersburg Mayor and City Council approved resolutions to terminate a pedestrian-bridge funding agreement, adopt a new intersection-improvements funding agreement with AstraZeneca affiliate Menimmune LLC, and approved a schematic development plan amendment for 200 Orchard Ridge Drive; all votes were unanimous.
The Gaithersburg Mayor and City Council on Sept. 2 approved two resolutions authorizing the city manager to negotiate and execute a revised funding agreement with Menimmune LLC (part of AstraZeneca) and to terminate an earlier pedestrian bridge funding agreement, and separately approved an amendment to the schematic development plan for 200 Orchard Ridge Drive.
The actions followed a presentation from City Attorney Frank Johnson and a staff presentation on the schematic development plan from planning staff. Johnson told the council the original pedestrian bridge funding agreement dated March 6, 2020, was being replaced by a new funding arrangement that redirects money toward targeted intersection and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
